Wie sind die Öffnungszeiten?

Montag 09:00 - 17:00 Dienstag 09:00 - 17:00 Mittwoch 09:00 - 17:00 Donnerstag 09:00 - 17:00 Freitag 09:00 - 17:00

DealMatrix

VALUATION I SCOUTING I MATCHING

DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings.

03/06/2026

🔥Our Deal of the Month May/26 is Isomorphic Labs

Isomorphic Labs, an AI-native drug discovery and development company, has announced a $2.1 billion Series B funding round aimed at accelerating the transition from breakthrough AI research to large-scale real-world drug development applications.

The round was led by Thrive Capital, with participation from existing investors Alphabet Inc. and GV (Google Ventures), alongside new backers including MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, further strengthening the company’s international investor base.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Isomorphic Labs operates at the intersection of biotechnology, artificial intelligence, and pharmaceuticals, with a focus on accelerating drug discovery through advanced AI models and computational life sciences research. Given the company’s current Series B stage, European benchmarks (Q1 2026) for AI-enabled biotechnology and pharmaceutical businesses indicate ⤵️

Valuation ranges of EV/Sales multiples of 3.61x - 4.99x, and EV/EBITDA multiples of 16.84x - 20.68x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

01/06/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #22: Focused Energy has closed a $240 million Series A financing round, setting a new benchmark as the largest fully funded Series A raise in the global fusion energy industry.

The round attracted support from RWE, SPRIND, the European Innovation Council Fund, and existing lead investor Prime Movers Lab.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Focused Energy operates at the intersection of clean technology, renewable energy, and deep technology, developing laser-driven fusion energy solutions to enable carbon-free and scalable power generation.

Given the company’s current Series A stage, European benchmarks (Q1 2026) for CleanTech, Renewable Energy, and DeepTech businesses indicate valuation ranges of EV/Sales multiples of 4.14x–8.91x and EV/EBITDA multiples of 14.12x–19.23x.

Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

26/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #21: Primer raises $100m Series C to scale AI payments platform

Primer, a digital payments orchestration platform, has raised $100 million in a Series C funding round to further advance its AI-powered operating layer designed for payments and finance teams.

The round was led by Sofina, with participation from Peak XV Partners.
Existing investors also took part, including Balderton Capital, Accel, ICONIQ Capital, Tencent, and Speedinvest.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Primer operates at the intersection of financial technology, payments, and enterprise software, providing a payment orchestration platform that enables merchants to optimize and manage payment operations through a unified infrastructure layer.

Given the company’s current Series C stage, European benchmarks (Q1 2026) for FinTech and Payments businesses indicate valuation ranges of EV/Sales multiples of 5.42x-7.19x, and EV/EBITDA multiples of 18.66x-20.51x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

18/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #20: Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine

Isomorphic Labs, an AI-native drug discovery and development company, has announced a $2.1 billion Series B funding round aimed at accelerating the transition from breakthrough AI research to large-scale real-world drug development applications.

The round was led by Thrive Capital, with participation from existing investors Alphabet Inc. and GV (Google Ventures), alongside new backers including MGX, Temasek, CapitalG, and the UK Sovereign AI Fund, further strengthening the company’s international investor base.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Isomorphic Labs operates at the intersection of biotechnology, artificial intelligence, and pharmaceuticals, with a focus on accelerating drug discovery through advanced AI models and computational life sciences research. Given the company’s current Series B stage, European benchmarks (Q1 2026) for AI-enabled biotechnology and pharmaceutical businesses indicate ⤵️

Valuation ranges of EV/Sales multiples of 3.61x - 4.99x, and EV/EBITDA multiples of 16.84x - 20.68x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

11/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #19: CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine

CellCentric, a biotechnology company focused on developing a novel treatment for multiple myeloma, announced on Wednesday that it has secured $220 million in a Series D financing round to support its mid- and late-stage clinical trials. The round was led by Venrock.

The Cambridge, U.K.- and Boston-based biotech company previously raised an additional $120 million in a Series C funding round last year, co-led by RA Capital Management and Forbion.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

CellCentric operates at the intersection of biotechnology and pharmaceuticals, with a focus on developing innovative therapeutic solutions and advancing life sciences research. Given the company’s current stage, European benchmarks (Q1 2026) for biotechnology and pharmaceutical businesses indicate valuation ranges of EV/Sales multiples of 3.61x - 4.99x, and EV/EBITDA multiples of 17.86x - 20.68x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform – Multiples Database at https://platform.dealmatrix.com

08/05/2026

🔥𝗢𝘂𝗿 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗠𝗼𝗻𝘁𝗵 𝗔𝗽𝗿𝗶𝗹/𝟮𝟲 𝗶𝘀 Blue Energy

Blue Energy raises $380M to build grid-scale nuclear reactors in shipyards

To accelerate development of its first power plant—a 1.5-gigawatt project in Texas scheduled to break ground later this year—Blue Energy has secured $380 million in financing, structured as a mix of equity and debt.

The round was led by VXI Capital, with participation from At One Ventures, Engine Ventures, and Tamarack Global.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Blue Energy operates in the sector of green tech and climate tech, building nuclear power plants, specifically modular ones manufactured in shipyards. In line with the company's current stage, European benchmarks (Q1 2026) for Greentech indicate valuation ranges of EV/Sales 6.06x - 7.79x and EV/EBITDA 11.15x - 14.34x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform: https://platform.dealmatrix.com

04/05/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #18: Former Google DeepMind researcher’s AI startup raises record $1.1 billion seed funding to pursue superintelligence

Ineffable Intelligence is targeting superintelligence and was founded in late 2025 by UCL professor and former head of DeepMind’s reinforcement learning team, David Silver. According to the company, its seed round is the largest ever raised in Europe, valuing the business at $5.1 billion.

The round was co-led by U.S. venture firms Sequoia Capital and Lightspeed, with additional backing from NVIDIA, DST Global, Index Ventures, Google, and the U.K.’s Sovereign AI Fund, among others.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Ineffable Intelligence operates in the field of artificial intelligence, with a focus on developing machine learning systems that improve through interaction and experiential learning. Given the company’s current stage, European benchmarks (Q1 2026) for AI and machine learning businesses indicate valuation ranges of EV/Sales multiples of 3.76x - 4.14x, and EV/EBITDA multiples of 16.84x - 18.96x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform: https://platform.dealmatrix.com

21/04/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #16: Adcendo Raises $75M Series C for ADC Pipeline

Adcendo, a Copenhagen-based clinical-stage biotech company developing first-in-class antibody-drug conjugates (ADCs) for high unmet-need cancers, has raised $75 million in an oversubscribed Series C round led by JEITO Capital.

The round brings in new investors including Vida Ventures, LLC, Bpifrance, and EIFO, alongside continued backing from existing investors such as RA Capital Management and TCGX.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

ADCendo operates in the biotechnology and pharmaceutical sector, developing targeted therapies at the intersection of advanced science and precision medicine. In line with its Series C stage, European benchmarks (Q4 2025) for Biotech and Pharmaceuticals indicate valuation ranges of EV/Sales 3.71x - 4.74x and EV/EBITDA 19.32x - 21.52x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform: https://platform.dealmatrix.com

13/04/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #15: Spain’s Xoople raises $130 million Series B to map the Earth for AI

Xoople (pronounced “zoople”) is building a satellite constellation designed to capture high-precision data for deep learning applications. Founded in 2019, the company has spent the past several years developing its technology stack, leveraging data from government spacecraft and integrating closely with major cloud providers.

The round was led by Nazca Capital. Additional investors include MCH Private Equity, , Buenavista Equity Partners (formerly GED Capital), and Endeavor Catalyst.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

Xoople operates at the intersection of artificial intelligence, geospatial data analytics, and climate technology, providing an AI-driven Earth intelligence platform that delivers high-resolution insights on environmental and physical changes.

Consistent with this positioning and the company’s Series B-stage profile, relevant European sector benchmarks as of Q4 2025 for data & analytics, applied AI, and CleanTech platforms indicate valuation ranges of EV/Sales 3.55x – 4.30x and EV/EBITDA 14.95x – 18.03x. Further information on valuation multiples in these sectors is available through the DealMatrix Platform.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform: https://platform.dealmatrix.com

07/04/2026

🔥 𝗗𝗲𝗮𝗹 𝗼𝗳 𝘁𝗵𝗲 𝗪𝗲𝗲𝗸 🔥 #14: 9fin raises $170M Series C at $1.3B valuation to scale AI platform for debt markets

The financing was led by HarbourVest Partners, with Canada Pension Plan Investment Board joining alongside existing backers redalpine, Highland Europe, Spark Capital, and Seedcamp.

👏 𝘊𝘰𝘯𝘨𝘳𝘢𝘵𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘵𝘦𝘢𝘮!

9fin operates at the intersection of artificial intelligence and financial market intelligence, providing an AI-powered platform that transforms debt market data into actionable insights for credit professionals.

Consistent with this positioning and the company’s Series C-stage financing, relevant European sector benchmarks as of Q4 2025 for Fintech and applied AI platforms indicate valuation ranges of EV/Sales 3.55x - 5.24x and EV/EBITDA 16.83x - 20.21x.

➡️ Further information on valuation multiples in these sectors is available through the DealMatrix Platform: https://platform.dealmatrix.com/

Adresse

Babenbergerstrasse 9
Vienna
1010

Öffnungszeiten

Montag	09:00 - 17:00
Dienstag	09:00 - 17:00
Mittwoch	09:00 - 17:00
Donnerstag	09:00 - 17:00
Freitag	09:00 - 17:00

Webseite

https://dealmatrix.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von DealMatrix erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.